Reply to Cimolai: Post-COVID syndrome and autoimmunity
J Infect Dis
.
2022 Sep 4;226(4):753-754.
doi: 10.1093/infdis/jiac106.
Authors
Yeny Acosta-Ampudia
1
,
Juan Manuel Anaya
1
2
Affiliations
1
Center for Autoimmune Diseases Research, School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia.
2
VaxThera, Bogotá, Colombia.
PMID:
35313345
DOI:
10.1093/infdis/jiac106
No abstract available
Publication types
Editorial
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Autoantibodies
Autoimmune Diseases*
Autoimmunity
COVID-19*
Humans
Lymphocyte Activation
Substances
Autoantibodies